The guidelines below were prepared by Pharmacy after research of the latest guidelines available from organizations like the IDSA, then reviewed with Infectious Disease physicians, customized for our institution, presented at the ASP committee, and then approved at P&T Committee. Check back regularly for new guidelines and recommendations. 

---

ABDOMINAL​

• Clostridium difficile

COVID-19

• COVID (Last updated on 2/28/22)

PULMONARY

• Community Acquired Pneumonia (CAP)
• Healthcare-Associated, Hospital-Acquired, Ventilator-Associated (HCAP/HAP/VAP)

skin & soft tissue

• Impetigo & Ecthyma
• Purulent SSTI
• Non-Purulent SSTI
• Surgical Site Infections
• Necrotizing Fasciitis/Gas Gangrene
• Pyomyositis
• Animal & Human Bites
• SSTI in Febrile Neutropenia
  • ID CONSULT RECOMMENDED
• SSTI in Immunodeficiency (lymphoma, lymphocytic leukemia, organ transplants, on anti-tumor necrosis factor (TNF) drugs or certain monoclonal antibodies)
  • ​​ID CONSULT RECOMMENDED

URINARY TRACT INFECTIONS​

• Asymptomatic Bacteriuria
• Cystitis & Pyelonephritis